Navigation Links
James B. Hawkins Appointed to IRIDEX Board of Directors
Date:10/15/2007

Natus Medical CEO Brings More Than 20 Years of Public Company Experience

MOUNTAIN VIEW, Calif., Oct. 15 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) announced today the appointment of James B. Hawkins, president and CEO of Natus Medical, Inc. (Nasdaq: BABY) to its Board of Directors.

"We are excited that Jim Hawkins has decided to become a part of the IRIDEX organization," said Theodore A. Boutacoff, chairman of the board at IRIDEX. "Jim brings to our Board more than 20 years of experience as a public company CEO, including 14 years in medical devices. We believe his medical device industry and operational experience will be highly valuable to IRIDEX. Throughout his career, Jim has executed strategic acquisitions, international expansion and other corporate initiatives designed to drive revenue and earnings growth. We look forward to his contributions."

Mr. Hawkins is currently the president, CEO and a director of Natus Medical, Inc., a developer, manufacturer and marketer of products for the detection, monitoring, treatment and tracking of common medical disorders in newborns. During his tenure at Natus, he has executed a growth strategy that focuses on sales force realignment, dramatic reductions in overhead expenses and revenue growth, which has resulted in a significant increase in operating margins, revenue and market capitalization. He has also initiated and negotiated numerous acquisitions which have been immediately accretive to earnings
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Blair Offers James Support To Fight AIDS
2. James Cook University urges more medical seats
3. Wood Appointed As the First Chair of SAADAT
4. Yoga Guru appointed Bihars brand ambassador
5. Disappointed Students Plan To Intensify Agitation Nationwide
6. City Surgeon Appointed Adviser To Armed Forces
7. Indian-American Appointed for US Hospital Top Post
8. Retiring Government Doctors to Be Reappointed to Overcome Paucity of Specialists
9. Study casts doubt on keyboard ills
10. Who Board To Discuss Asian Tsunami Related Health Issues
11. Abdominal Crunches Not The Best Option For Wash Board Abs.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... Conn., July 24 /PRNewswire/ -- People think it,s ...ffer many opportunities to eat right,and stay fit....t menu,selections, so if you order carefully your ...o: http://www.newscom.com/cgi-bin/prnh/20071212/N...mptation, you,ll want to stay,away from the cruise...
(Date:7/24/2008)... Greater access for people with disab...oad on ,Social Security disability system. , ...24, 2008 -- With the signing of the Americans with...n in the lives of people with disabilities and the... gained better access to methods that help them im...
(Date:7/24/2008)... A cleanroom manufacturing company ha...cleanrooms. The feature is a utility panel which ...hance the cleanroom appearance. , ...- Gerbig Engineering, a designer, fabricator and i...t they are now offering a utility panel for integr...
(Date:7/24/2008)... As America's baby boomers age, ...itions such as diabetes that necessitate the use o...t bracelet jewelry gives a generation attractive i...mation. , (PRWEB) July 24...tening health conditions can make a statement in m...
Breaking Medicine News(10 mins):Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Treat Yourself To a Healthy Cruise 2Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Treat Yourself To a Healthy Cruise 3Health News:Allsup Salutes 18th Anniversary of Americans with Disabilities Act 2Health News:Allsup Salutes 18th Anniversary of Americans with Disabilities Act 3Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2Health News:Aging Baby Boomers Meld Life-saving Data and Style with Lauren's Hope Fashion Medical ID Bracelet 2Health News:Aging Baby Boomers Meld Life-saving Data and Style with Lauren's Hope Fashion Medical ID Bracelet 3
...risk of heart disease through causing inflammation...gum infection may set the scene for heart disease.... the heart - C - reactive protein (CRP). Researche...hat people with gum disease have higher than norma...
...ess is being collected on a database which both do...gredient in medical research is the patient's voic...s, but doctors and researchers could learn a lot f...ut their illness. It would help new patients too -...
...ancreas can benefit from 'keyhole' surgery, accord...surgery is increasing in popularity for a number o...ar and less time in hospital after the operation. ...ough which miniature instruments are inserted. The...
...isease also improves the paralysis experienced by ...transmitter dopamine in the body, and this may hel...function more normally. It's used as a treatment i... that levodopa is also helpful in alleviating stro...
Other Medicine News:
(Date:7/23/2008)... BOSTON, July 23 /- FluoroPharma ...imaging agents for the Positron Emission Tomograph... for BFPET, its novel,Fluorine-18 labeled tracer f...arma,s second cardiovascular product to complete P...ing agent, designed to assess the blood flow in th...
(Date:7/23/2008)... Company Focused on IND-Enabling Work with Pro...ive Pathway of Complement System, CAMBRIDGE, Mass...c.,today announced it has initiated a corporate gr...Ph.D., as chief executive officer and the,establis...Celniker succeeds,Woodruff Emlen, M.D., a co-found...
(Date:7/22/2008)... Latest awards under Therapeutics Development ...llaborations to 23; next deadline January 20,2009... part of its mission to,speed delivery of transfor...se, The Michael J. Fox Foundation for Parkinson,s ... to six industry research teams. The awards,were g...
(Date:7/22/2008)... Two Regimens Including Lantus(R) and Apidra(R)...ients with Type 2 Diabetes, Whatever the Algorithm...ER, N.J., July 22 /- Results from the...of a Simple Algorithm to Carbohydrate,Counting for...were,published in the American Diabetes Associatio...
Breaking Medicine Technology:FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Front Line Caregiver Coalition Thanks Sens Conrad Coleman and Reps Pomeroy Capito and Berkley for Leading Bipartisan Hill Effort to Stop Bush Admi 21200 1Front Line Caregiver Coalition Thanks Sens Conrad Coleman and Reps Pomeroy Capito and Berkley for Leading Bipartisan Hill Effort to Stop Bush Admi 21200 2Cline Davis 26 Mann Launches Platform Advisors 28TM 29 a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pha 21197 1Cline Davis 26 Mann Launches Platform Advisors 28TM 29 a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pha 21197 2Niacins role in maintaining good cholesterol 3545 1Duke chemist has new way to tell right from left 21192 1Duke chemist has new way to tell right from left 21192 2
For the direct, colorimetric determination of calcium in human serum or urine. Linearity: 20 mg/dl.
Alanine Aminotransferase (ALT) reagent is used for the quantitative determination of alanine aminotransferase (Glutamate pyruvate transaminase, SGPT) in human serum.
For the quantitative determination of Alanine Aminotransferase in serum. Optimized IFCC without P-5'-P, Linearity: 500 IU/L at 37 C. Liquid Working Reagent prepared with simple 1:9 dilution.
For the determination of urea nitrogen in human serum.
Medicine Products: